Staphylococcus aureus - Xen8.1 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain 8325-4. Staph. aureus-Xen8.1 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. PerkinElmer's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:
免责声明: For laboratory use only. This product is intended for animal research only and not for use in humans.
|产品尺寸||1 agar plate|
|技术说明||Bacterial Growth Preparation||PDF 26 KB|
|产品手册||In Vivo Imaging Agents Brochure||PDF 2 MB|
|Citations Library||View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents||链接|
|网络研讨会||View our complete list of in vivo webinars available on demand||链接|